Global Cardiovascular Ultrasound Market to reach USD 2.4 billion by 2027. Global Cardiovascular Ultrasound Market is valued approximately USD 1.6 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 5.9 % over the forecast period 2021-2027. The cardiovascular ultrasound market is projected to expand as preventative medicine becomes more widely used and the prevalence of cardiovascular diseases (CVDs) rises. Outpatient imaging services were negatively impacted by the COVID-19 pandemic, which hindered worldwide market growth. Coronary heart disease, heart attack, and stroke are among the most common causes of mortality in the United States. CVD susceptibility has risen as a result of changing lifestyle. According to the CDC, 28.2 million individuals in the United States were diagnosed with heart disease in 2017. Ultrasound technology is used to check for anomalies in the heart's function, such as cardiac pumping capacity, valve function, and plaque in the heart. These gadgets serve as crucial diagnostic tools that can aid in the prevention of heart attacks and strokes by detecting them early. As a result, the market is expected to be driven by the rising prevalence of cardiac diseases throughout the projected period. However, issues such as unfavorable reimbursement situations and the cost of adopting new technologies are anticipated to stymie the market's expansion throughout the projection period. Artificial intelligence, on the other hand, has had a substantial beneficial influence on cardiology, with enhanced diagnostic skills for specific cardiac diseases. For instance, GE Healthcare got FDA 510k clearance in October 2020 for its extreme edition package of vivid cardiovascular ultrasound equipment, which incorporates new AI-based capabilities that enable physicians to acquire quicker and more reproducible examinations regularly.


The main regions of Asia Pacific, North America, Europe, Latin America, and the Rest of the World are included in the geographical analysis of the worldwide Cardiovascular Ultrasound market. Along with increased infrastructure in healthcare institutions and widespread use of CVUS in preventive medicine, North America held the biggest revenue share of more than 29% in 2020. Medicare payments are based on a variety of variables in the United States, including relative value units, conversion factors, and regional practice cost indexes. The Medicare programme has new laws that govern reimbursement policies. Over the projected period, the favourable reimbursement policy and regulatory framework will help to promote market expansion in this area. However, Asia Pacific is projected to be the fastest-growing regional market. The rising incidence of chronic diseases in the region is contributing to this rise.
Major market player included in this report are:
GE Healthcare
Koninklijke Philips
Siemens Healthineers AG
Hitachi Medical Corp.
Samsung Medison Co. Ltd.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Mindray)
Chison Wuxi Xiangsheng Medical Technology Co., Ltd.
Fujifilm Sonosite, Inc.
Toshiba Medical Systems Corporation
Philips Healthcare
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Mode of Operation offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Transthoracic Echocardiography
Transesophageal Echocardiography
Fetal Echocardiography
Others
By Technology:
2D
3D/4D
Doppler
By Display:
B/W
Color
By End-use:
Hospital
Diagnostic Centers
Ambulatory Care Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027

Target Audience of the Global Cardiovascular Ultrasound Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors